GlassScriptPhysician profile
Hugh Mai
NPI 1710921903
$1,067.82
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $163 · 2021: $145 · 2022: $35.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.21 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.97 | 2019-2021 | |
| Boston Scientific Corporation | $118.31 | 2019 | |
| Endogastric Solutions, INC | $110.36 | 2019 | |
| Gilead Sciences, INC. | $106.64 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $84.77 | 2019-2020 | |
| Shionogi INC | $43.82 | 2019 | |
| Janssen Biotech, INC. | $35.92 | 2022 | |
| Ferring Pharmaceuticals INC. | $28.52 | 2019 | |
| Allergan, INC. | $24.85 | 2019-2020 | |
| Qol Medical, LLC | $23.39 | 2021 | |
| Redhill Biopharma INC. | $18.48 | 2020 | |
| Intercept Pharmaceuticals, INC. | $16.54 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.47 | 2021 | |
| Braintree Laboratories, INC. | $15.23 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $13.56 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.65 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.13 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Mai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.